Cyient Limited has announced the record date for its proposed buyback of equity shares. The company has fixed Wednesday, June 17, 2026, as the record date to determine eligible shareholders for the buyback. This follows earlier intimations regarding the Board and shareholder approvals for a buyback of up to 64,00,000 equity shares at a price of INR 1,125 per share.
Cyient Limited Announces Record Date for Equity Share Buyback
Cyient Limited has officially set the record date for its ongoing equity share buyback program. The company has determined that Wednesday, June 17, 2026, will serve as the record date for the purpose of identifying eligible equity shareholders entitled to participate in the buyback. This date is crucial for determining who will receive the buyback offer based on their holdings on that specific day.
Buyback Details Confirmed
This announcement comes as a follow-up to previous communications informing stakeholders about the buyback. The company’s Board of Directors and shareholders had previously approved a proposal to buy back up to 64,00,000 fully paid-up equity shares. Each share has a face value of INR 5. The aggregate amount earmarked for this buyback does not exceed INR 720,00,00,000. The buyback price has been fixed at INR 1,125 per equity share.
Regulatory Compliance
The buyback is being conducted in accordance with the provisions of the Companies Act, 2013, read with the relevant rules, and the Securities and Exchange Board of India (Buy-Back of Securities) Regulations, 2018. The company has ensured compliance with all applicable laws and regulations throughout this process.
Additional Information for U.S. Investors
For investors in the United States, it is noted that the buyback has not yet commenced. This communication is for informational purposes only and does not constitute an offer to purchase or a solicitation of an offer to sell any securities. Any formal offer to purchase or solicitation of offers to sell will be made through a separate letter of offer and other relevant documents.
Source: BSE
